Objective: The aim of this study is to verify in an isolated working heart swine model if the acute administration of trimetazidine to cardioplegia, without pre=treatment improves heart performance. Methods: Eighteen pairs of swines were used in this working heart model, divided into three groups (n = 6) that underwent regional and global ischemia. Each group was selected to a different treatment: St Thomas cardioplegia (ST), St Thomas enriched with trimetazidine (TMZ) and control group (Co). Data was collected during reperfusion period at 30, 60 and 90 minutes. Hemodinamic parameters such as elastance contractility index (Emax), preload recruitable stroke work relationship (PRSW) and heart "stiffness" (EDPVR) were measured. Other data included coronary flow, lactate, oxygen and glucose consumption. Results were statistically analyzed. Results: All contractility data were not significantly different among three groups. Lactate became constantly higher according to time uniformly in all three groups. Coronary flow, glucose consumption and oxygen consumption presented large variations during time periods but according to treatments showed no statistical differences in all three groups. Left ventricle final weight was significantly lower in trimetazidine group compared to both other groups. Conclusion: Administration of trimetazidine enhanced cardioplegia, without pre-treatment, showed no hemodinamic or metabolic improvement in swine isolated working heart model.232224234Desideri, A., Celegon, L., Metabolic management of ischemic heart disease: Clinical data with trimetazidine (1998) Am J Cardiol, 82 (5 A), pp. 50K-53KLavanchy, N., Martin, J., Rossi, A., Anti-ischemic effects of trimetazidine: 31P-NMR spectroscopy in the isolated rat heart (1987) Arch Int Pharmacodyn Ther, 286 (1), pp. 97-110Belardinelli, R., Trimetazidine and the contractile response of dysfunctional myocardium in ischaemic cardiomiopathy (2000) Rev Port Cardiol, 19 (SUPPL. 5), pp. V35-V39Knight, C., Fox, K., From antianginal drugs to myocardial cytoprotective agents (1995) Am J Cardiol, 76 (6), pp. 4B-7BStanley, W.C., Changes in cardiac metabolism: A critical step from stable angina to ischaemic cardiomiopathy (2001) Eur Heart J, 3 (SUPPL.), pp. 2-7Fabiani, J.N., Ponzio, O., Emerit, I., Massonet-Castel, S., Paris, M., Chevalier, P., Cardioprotective effect of trimetazidine during coronary artery graft surgery (1992) J Cardiovasc Surg, 33 (4), pp. 486-491Vedrinne, J.M., Vedrinne, C., Bompard, D., Lehot, J.J., Boissel, J.P., Champsaur, G., Myocardial protection during coronary artery bypass graft surgery: A randomized, double-blind, placebo-controlled study with trimetazidine (1996) Anaesth Analg, 82 (4), pp. 712-718Tünerir, B., Colak, O., Alatas, O., Besogul, Y., Kural, T., Aslan, R., Measurement of troponin T to detect cardioprotective effect of trimetazidine during coronary artery bypass grafting (1999) Ann Thorac Surg, 68 (6), pp. 2173-2176Colégio Brasileiro de Experimentação Animal. Princípios éticos na experimentação animal. In: São Paulo:Congresso do Colégio Brasileiro de Experimentaç ão Animal1991Budrikis, A., Bolys, R., Liao, Q., Ingemansson, R., Sjöberg, T., Steen, S., Function of adult pig hearts after 2 and 12 hours of cold cardioplegic preservation (1998) Ann Thorac Surg, 66 (1), pp. 73-78Brooks, W.W., Healey, N.A., Sen, S., Conrad, C.H., Bing, O.H., Oxygen cost of stress development in hypertrophied and failing hearts from the spontaneously hypertensive rat (1993) Hypertension, 21 (1), pp. 56-64Petrucci Jr O. Estudo comparativo entre solução cardioplégica cristalóide e microcardioplegia sanguínea normotérmica em corações agudamente isquêmicos [Tese de Doutorado]. Campinas:Universidade Estadual de Campinas;2004Detry, J.M., Leclercq, P.J., Trimetazidine European Multicenter Study versus propranolol in stable angina pectoris: Contribution of Holter electrocardiographic ambulatory monitoring (1995) Am J Cardiol, 76 (6), pp. 8B-11BMarzilli, M., Klein, W.W., Efficacy and tolerability of trimetazidine in stable angina: A meta-analysis of randomized, double-blind, controlled trials (2003) Coron Artery Dis, 14 (2), pp. 171-179Cesar, L.A.M., Dallan, L.A., Gowdak, L.H.W., Lisboa, L.A.F., Moretti, M.A., Alternatives for the treatment of angina pectoris: New drugs, external counterpulsation, spinal-cord stimulation for analgesia, therapeutic angiogenisis and transmyocardial revascularization (2003) Rev Soc Cardiol Estado de São Paulo, 13 (2), pp. 240-253Braile, D.M., Cardioplegia sanguínea isotérmica anterógrada e retrógrada de baixo volume (1997) São José do Rio PretoHerrmann, J.L.V., Stefanini, E., Drug therapy. Choosing the best schedule (2003) Rev Soc Cardiol Estado de São Paulo, 13 (2), pp. 196-203Stanley, W.C., Cardiac energetics during ischemia and the rationale for metabolic interventions (2001) Coron Artery Dis, 12 (SUPPL. 1), pp. 53-57Pichon, G., Rousseau, D., Helies, C., Control by Trimetazidine of the energy substrate balance in ventricular myocite (1999) J Moll Cell Cardiol, 31, pp. A88Rodrigues, A.J., Vicente, W.V.A., Carneiro, J.J., Bassetto, S., Cardioplegia sanguínea anterógrada intermitente normotérmica e hipotérmica: Estudo comparativo em corações agudamente isquêmicos de coelhos. (2000) Rev Bras Cir Cardiovasc, 15 (3), pp. 238-250Rodrigues, A.J., Sader, A.A., Vicente, W.V.A., Bassetto, S., Cardioplegia sanguínea normotérmica intermitente anterógrada. II. Com e sem aminoácidos: Estudo comparativo em coelhos. (1997) Rev Bras Cir Cardiovasc, 12 (4), pp. 340-347Horsley, W.S., Whitlark, J.D., Hall, J.D., Gott, J.P., Huang, P.-C.A.H., Revascularization for acute regional infarct: Superior protection with warm blood cardioplegia (1993) Ann Thorac Surg, 56 (6), pp. 1228-1237Grossman, W., Braunwald, E., Mann, T., McLaurin, L.P., Green, L.H., Contractile state of the left ventricle in man as evaluated from end-systolic pressure-volume relations (1977) Circulation, 56 (5), pp. 845-852Glower, D.D., Spratt, J.A., Snow, N.D., Kabas, J.S., Davis, J.W., Olsen, C.O., Linearity of the Frank-Starling relationship in the intact heart: The concept of preload recruitable stroke work (1985) Circulation, 71, pp. 994-1009Guyton RA. A synopsis of cardiac physiology. In: Edmunds LH. Cardiac surgery in the adult. 1st ed. New York:McGrawHill Companies;1997. p.59-84Petrucci Júnior, O., Oliveira, P.P., Carmo, M.R., Vieira, R.W., Braile, D.M., Standardization of an isolated pig heart preparation with parabiotic circulation: Methodological considerations (2003) Braz J Med Biol Res, 36 (5), pp. 649-659Allibardi, S., Chierchia, S.L., Margonato, V., Merati, G., Neri, G., Dell'Antonio, G., Effects of trimetazidine on metabolic and functional recovery of postischemic rat hearts (1998) Cardiovasc Drugs Ther, 12 (6), pp. 543-549Kantor, P.F., Lucien, A., Kozak, R., Lopaschuk, G.D., The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase (2000) Circ Res, 86 (5), pp. 580-588Kober, G., Buck, T., Sievert, H., Vallbracht, C., Myocardial protection during percutaneous transluminal coronary angioplasty: Effects of trimetazidine (1992) Eur Heart J, 13 (8), pp. 1109-1115Beygui, F., Trimetazidine as adjunctive therapy to primary PTCA for acute myocardial infarction (2000) Rev Port Cardiol, 19 (SUPPL. 5), pp. V31-V34Steg, P.G., Grollier, G., Gallay, P., Morice, M., Karrillon, G.J., Benamer, H., A randomized double-blind trial of intravenous trimetazidine as adjunctive therapy to primary angioplasty for acute myocardial infarction (2001) Int J Cardiol, 77 (2-3), pp. 263-273Group. Effect of 48-h intravenous trimetazidine on short- and long-term outcomes of patients with acute myocardial infarction, with and without thrombolitic therapyA double-blind, placebo-controlled, randomized trial. The EMIP-FR Group. European Myocardial Infarction Project-Free Radicals (2000) Eur Heart J, 21 (18), pp. 1537-1546. , The European Myocardial Infarction Project-Free Radicals EMIP-FRGrynberg, A., The EMIP-FR Study: The evolution of scientific background as a non-controlled parameter (2001) Eur Heart J, 22 (11), pp. 975-977Ikizler, M., Erkasap, N., Dernek, S., Batmaz, B., Kural, T., Kaygisiz, Z., Trimetazidine-induced enhancement of myocardial recovery during reperfusion: A comparative study in diabetic and non-diabetic rat hearts (2006) Arch Med Res, 37 (6), pp. 700-708Ikizler, M., Dernek, S., Sevin, B., Kural, T., Trimetazidine improves recovery during reperfusion in isolated rat hearts after prolonged ischemia (2003) Anadolu Kardiyol Derg, 3 (4), pp. 303-308Onay-Besikci, A., Guner, S., Arioglu, E., Ozakca, I., Ozcelikay, A.T., Altan, V.M., The effects of chronic trimetazidine treatment on mechanical function and fatty acid oxidation in diabetic rat hearts (2007) Can J Physiol Pharmacol, 85 (5), pp. 527-535